A Drug Use Investigation of Enbrel for Post-Marketing Surveillance (PMS) for Ankylosing Spondylitis

Trial Profile

A Drug Use Investigation of Enbrel for Post-Marketing Surveillance (PMS) for Ankylosing Spondylitis

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2009

At a glance

  • Drugs Etanercept (Primary)
  • Indications Ankylosing spondylitis
  • Focus Adverse reactions
  • Sponsors Wyeth
  • Most Recent Events

    • 22 Sep 2009 Actual end date (1 Aug 2008) added as reported by ClinicalTrials.gov.
    • 22 Sep 2009 Actual patient number (526) added as reported by ClinicalTrials.gov.
    • 22 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top